business / news / / ThePrint
Sun Pharma announced Monday that it has entered into an agreement to acquire New Jersey-headquartered Organon in an all-cash deal valued at $11.75 billion.
Sun Pharma will acquire Organon for $11.75 billion in an all-cash deal.
KEY POINTS
- This acquisition will position Sun Pharma among the top 25 pharmaceutical companies globally by revenue.
- The deal marks Sun Pharma’s entry into biosimilars, making it the seventh largest biosimilars player.
- Sun Pharma’s women’s health portfolio will expand, making it one of the top three players in this segment.
COMPANIES
Summarized by Newsio from ThePrint. How we summarize →